ATLASGeneDx (WGS) earnings date: Nov 9, 2026
GeneDx (WGS) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of $0.07.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on WGS
| Last price | $67.67 (-2.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 6 reports |
These figures come from the same calibrated model and valuation as the GeneDx stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
GeneDx reports on Nov 9, 2026. One email the day before, with ATLAS’s read on GeneDx. You can switch it off at any time.
Alert me before WGS reportsFree to start. Creating an account takes under a minute.
Notify me when GeneDx reports
Track WGS free Add GeneDx to a free ATLAS watchlist and see its next report date in one place.
WGS earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.07 |
| Last report | Oct 27, 2026 · Miss |
| Beat rate (last 6 reports) | 3 of 6 (50%) |
| Average EPS surprise | -276.9% |
| Average move around a report | ±11.3% (last 6) |
| Sector | Healthcare · Diagnostics & Research |
GeneDx earnings history: last 6 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 27, 2026 | $0.07 | – | -100.0% | Miss | +5.6% |
| Aug 3, 2026 | -$0.19 | $0.01 | +105.3% | Beat | +8.9% |
| May 4, 2026 | -$0.02 | -$0.28 | -1,300.0% | Miss | -47.2% |
| Feb 23, 2026 | $0.12 | $0.14 | +16.7% | Beat | -1.7% |
| Dec 10, 2025 | -$0.01 | -$0.05 | -400.0% | Miss | -3.4% |
| Oct 28, 2025 | $0.42 | $0.49 | +16.7% | Beat | +0.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for WGS
See the fair value, the probability range and the earnings history of GeneDx on its ATLAS page.
GeneDx (WGS) stock analysisPlans from €3.99 a month.
GeneDx earnings: frequently asked questions
When does GeneDx (WGS) report earnings?
GeneDx is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for WGS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.07 per share (USD). Estimates can change before the report.
How often does WGS beat earnings estimates?
Of its last 6 reports with a recorded result, GeneDx beat the EPS estimate 3 times; the average surprise was -276.9%. Past results do not predict the next one.
How much does WGS move around earnings?
Over its last 6 reports the stock moved an average of 11.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 6 times.
How much does WGS usually move in a day?
On a normal trading day the ATLAS model puts WGS’s one-day range at about ±5.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer